Logo image
The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: A comparison with albendazole
Journal article   Peer reviewed

The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: A comparison with albendazole

A. Armson, R.C.A. Thompson, J.A. Reynoldson, W.B. Grubb and A.H.W. Mendis
International Journal for Parasitology, Vol.23(6), pp.815-817
1993
url
Link to Published Version *Subscription may be requiredView

Abstract

The clinical efficacy of albendazole (ABZ) in the treatment of chronic uncomplicated strongyloidiasis has been reported to be highly variable. In our murine model of strongyloidiasis a single oral dose of 5 and 10 mg kg-1 ABZ reduced (at day 4 post infection) the faecal larval count (FLC) by 54.2 ± 12.5% and 81.5 ± 10.2%, respectively. 100 mg kg-1 ABZ reduced the FLC by 100%. Two inhibitors of protozoan and filarial electron transport (720C80 and 993C76) inhibited the endogenous O2 consumption of intact infective (L3) larvae of S. ratti by > 50% at 2 x 10-5 M in vitro, and reduced the FLC by 72 ± 9.3% and 62.0 ± 10.3% respectively in vivo, at a dose of 70 mg kg-1. These results suggest that compounds designed as selective inhibitors of protozoan electron transport have significant efficacy against murine strongyloidiasis and may prove useful in the management of human strongyloidiasis.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.163 Parasitology - General
1.163.1393 Filarial Infections
Web Of Science research areas
Parasitology
ESI research areas
Microbiology
Logo image